Evidence map›Paper›PMID 35209958›Full record

ReviewFungal biology and biotechnology2022

Risk assessment of fungal materials.

Jeroen G van den Brandhof, Han A B Wösten

Abstract readReview
In one paragraph

Review in Fungal biology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Harnessing Fungi Signaling in Living Composites.Global challenges (Hoboken, NJ) · 2024
    Article
  6. Article
  7. Review
  8. The Possibility of Using Sulphur Shelf Fungus (Foods (Basel, Switzerland) · 2023
    Review
  9. Electrical response of fungi to changing moisture content.Fungal biology and biotechnology · 2023
    Article
  10. Mycelium-Based Composite Materials: Study of Acceptance.Materials (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Article
  13. Mushrooms as future generation healthy foods.Frontiers in nutrition · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeroen G van den BrandhofMicrobiology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Han A B WöstenMicrobiology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands. h.a.b.wosten@uu.nl.ORCID http://orcid.org/0000-0002-0399-3648

Funding

Horizon 2020 Framework Programme 858132 Fungar
6 · The paper itself

Abstract

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile. The properties of fungal materials depend on the type of fungus and substrate, the growth conditions and post-treatment of the material. So far, fungal materials are mainly made with species from the phylum Basidiomycota, selected for the mechanical and physical properties they provide. However, for mycelium materials to be implemented in society on a large scale, selection of fungal species should also be based on a risk assessment of the potential to be pathogenic, form mycotoxins, attract insects, or become an invasive species. Moreover, production processes should be standardized to ensure reproducibility and safety of the product.

Indexed as

Biobased materialFungal materialFungusMushroom forming fungusMycelium materialPathogenic fungus

Identifiers

PMID35209958
PMCPMC8876125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.